Delicate Difference: More Surgical Options for Prostate Cancer
Innovative approaches offer more surgical options with potentially fewer side effects.
Read More
Added Benefits: Health Care Reform
What healthcare reform means for people with cancer.
Non-Traditional Methods to Pay for Cancer Care Pays Off
Patients battling cancer get financial assistance from friends, family, social media and non-profit organizations.
Novel Cytokines for RCC
The human body sometimes produces its own immune response to renal cell carcinoma that results in spontaneous disease remission.
Should Breast Cancer Patients Make the Switch?
Is it best to start with tamoxifen and then switch to an aromatase inhibitor (AI), or should the AI come first?
Looking for the Optimal Treatment Schedule for Taxanes
A discussion about the best schedule for a class of drugs continues at the San Antonio Breast Cancer Symposium.
Understanding Metastasis
How a better understanding of cancer metastasis is suggesting better treatment approaches.
A Winning Combination
A combination of two well known breast cancer drugs could prove very successful when treating hormone receptor-positive, HER2-positive metastatic disease.
The Jury Is In
News from SABCS: Aromatase inhibitors are more effective than tamoxifen.
New Ways of Studying Drugs are Needed to Succeed in Developing New Agents
Overview of education sessions during opening of SABCS.
Renaissance Surgery
Using robotic arms, video cameras, and tiny incisions, cancer surgeons are changing what it means to go under the knife.
Donald L. Morton: Looking for a Better Way
Donald L. Morton, cancer researcher, revolutionized breast cancer surgery with the sentinal lymph node biopsy.
Oncoplastic Surgery for Breast Cancer
Oncology surgeons are being trained in a new field that combines the surgical removal of breast cancer with breast reconstruction.
The New Sarcoma Story
Strategies for diagnosing and treating sarcomas shift to a more patient-specific approach.
Secondary Sarcomas
Some cancer therapies can increase the risk of secondary cancers such as sarcoma, especially for childhood cancer survivors.
Surgeons and Robots
Minimally invasive technologies transform the landscape of cancer surgery.
Less Can Be More in Diagnostic Imaging
Minimally invasive techniques help detect and diagnose cancer earlier.
Bladder Cancer: Breaking the Research Barrier
Influential Factors
In Situ Breast Cancer: Is It Really Cancer?
Status of noninvasive breast cancer gets some clarity.
Watch It or Treat It?
Many experts consider lobular carcinoma in situ, LCIS, to be a precursor to invasive breast cancer, but there is still debate over the best treatment including surgery and prevention with tamoxifen or Evista.
Do Women Under 50 Need Mammograms?
The risks and benefits of mammography screening vary by age—the benefit for women over age 50 has been proven, but debate continues about the benefit of screening younger women, beginning at age 40.
Taking Control
Cancer survivors deal with fear.
Picking Up Momentum for Treating Renal Cell Carcinoma
Advanced treatments take form for a notoriously hard-to-beat cancer.
v4n2 - Disrupting Metastasis
v4n2 - The Future of Metastasis Treatment